• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Lower Incidence of Hypoglycemia With Angiotensin Receptor Blocker Versus ACE Inhibitor Therapy in People With or Without Diabetes.血管紧张素受体阻滞剂与血管紧张素转换酶抑制剂治疗糖尿病或非糖尿病患者时低血糖发生率较低。
Clin Diabetes. 2024 Spring;42(2):300-307. doi: 10.2337/cd23-0039. Epub 2024 Jan 12.
2
Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension: A Single-Center Retrospective Study.血管紧张素 II 受体阻滞剂和 ACE（血管紧张素转换酶）抑制剂对 COVID-19 合并高血压患者病毒感染、炎症状态和临床结局的影响：一项单中心回顾性研究。
Hypertension. 2020 Jul;76(1):51-58. doi: 10.1161/HYPERTENSIONAHA.120.15143. Epub 2020 Apr 29.
3
Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease.荟萃分析：肾素血管紧张素系统抑制剂单药治疗及联合治疗对肾病蛋白尿的影响
Ann Intern Med. 2008 Jan 1;148(1):30-48. doi: 10.7326/0003-4819-148-1-200801010-00190. Epub 2007 Nov 5.
4
Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.血管紧张素转换酶（ACE）抑制剂与血管紧张素受体阻滞剂治疗原发性高血压的比较。
Cochrane Database Syst Rev. 2014 Aug 22;2014(8):CD009096. doi: 10.1002/14651858.CD009096.pub2.
5
Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.在随机VATTC试验中血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂与预防角质形成细胞癌的关联
J Natl Cancer Inst. 2008 Sep 3;100(17):1223-32. doi: 10.1093/jnci/djn262. Epub 2008 Aug 26.
6
The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies.SARS-CoV-2 的受体 ACE-2 在许多不同的细胞类型上表达：对基于 ACE 抑制剂和血管紧张素 II 受体阻滞剂的心血管治疗的影响。
Intern Emerg Med. 2020 Aug;15(5):759-766. doi: 10.1007/s11739-020-02364-6. Epub 2020 May 19.
7
Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials.肾素-血管紧张素系统抑制剂在慢性肾脏病患者的肾脏和心血管结局中的作用：一项随机临床试验的贝叶斯网络荟萃分析。
Am J Kidney Dis. 2016 May;67(5):728-41. doi: 10.1053/j.ajkd.2015.10.011. Epub 2015 Nov 18.
8
Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis.血管紧张素转换酶抑制剂和血管紧张素Ⅱ受体拮抗剂与其他降压药物治疗糖尿病患者的疗效比较：系统评价和贝叶斯网状meta 分析。
BMJ. 2013 Oct 24;347:f6008. doi: 10.1136/bmj.f6008.
9
Summary of AHRQ's comparative effectiveness review of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers added to standard medical therapy for treating stable ischemic heart disease.美国医疗保健研究与质量局（AHRQ）对添加到标准药物治疗中用于治疗稳定型缺血性心脏病的血管紧张素转换酶抑制剂或血管紧张素II受体阻滞剂的比较疗效评价总结。
J Manag Care Pharm. 2011 Jun;17(5 Suppl):S1-15. doi: 10.18553/jmcp.2011.17.s5.1.
10
Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on All-Cause Mortality and Renal Outcomes in Patients with Diabetes and Albuminuria: a Systematic Review and Meta-Analysis.血管紧张素转换酶抑制剂和血管紧张素II受体阻滞剂对糖尿病和蛋白尿患者全因死亡率及肾脏结局的影响：一项系统评价和荟萃分析
Kidney Blood Press Res. 2018;43(3):768-779. doi: 10.1159/000489913. Epub 2018 May 22.

本文引用的文献

1
6. Glycemic Targets: Standards of Care in Diabetes-2023.6. 血糖目标：2023 年糖尿病护理标准。
Diabetes Care. 2023 Jan 1;46(Suppl 1):S97-S110. doi: 10.2337/dc23-S006.
2
11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2023.11. 慢性肾脏病与风险管理：2023 年糖尿病护理标准。
Diabetes Care. 2023 Jan 1;46(Suppl 1):S191-S202. doi: 10.2337/dc23-S011.
3
Prediction of Hypoglycemia During Admission of Non-Critically Ill Patients: Results from the MENU Study.非危重症住院患者低血糖预测：MENU 研究结果。
Horm Metab Res. 2020 Sep;52(9):660-668. doi: 10.1055/a-1181-8781. Epub 2020 Jul 6.
4
Systemic Treatment With Glucocorticoids Is Associated With Incident Hypoglycemia and Mortality: A Historical Prospective Analysis.全身用糖皮质激素治疗与低血糖事件和死亡率相关：一项历史前瞻性分析。
Am J Med. 2020 Jul;133(7):831-838.e1. doi: 10.1016/j.amjmed.2019.12.026. Epub 2020 Jan 23.
5
Reduction of serum albumin in non-critically ill patients during hospitalization is associated with incident hypoglycaemia.住院期间非危重症患者血清白蛋白降低与低血糖事件有关。
Diabetes Metab. 2020 Feb;46(1):27-32. doi: 10.1016/j.diabet.2019.03.003. Epub 2019 Apr 11.
6
Documented hypoglycemia is associated with poor short and long term prognosis among patients admitted to general internal medicine departments.在内科住院患者中，有记录的低血糖与短期和长期预后不良相关。
Diabetes Metab Syndr. 2019 Jan-Feb;13(1):222-226. doi: 10.1016/j.dsx.2018.07.004. Epub 2018 Jul 17.
7
Angiotensin receptor blockers: pharmacology, efficacy, and safety.血管紧张素受体阻滞剂：药理学、疗效和安全性。
J Clin Hypertens (Greenwich). 2011 Sep;13(9):677-86. doi: 10.1111/j.1751-7176.2011.00518.x. Epub 2011 Jul 27.
8
Angiotensin-converting enzyme inhibitors.血管紧张素转化酶抑制剂。
J Clin Hypertens (Greenwich). 2011 Sep;13(9):667-75. doi: 10.1111/j.1751-7176.2011.00508.x. Epub 2011 Jul 18.
9
Angiotensin-converting enzyme insertion/deletion polymorphism and severe hypoglycemia complicating type 2 diabetes: the Fremantle Diabetes Study.血管紧张素转化酶插入/缺失多态性与 2 型糖尿病并发严重低血糖：弗里曼特尔糖尿病研究。
J Clin Endocrinol Metab. 2011 Apr;96(4):E696-700. doi: 10.1210/jc.2010-2087. Epub 2011 Feb 2.
10
A new equation to estimate glomerular filtration rate.一种估算肾小球滤过率的新公式。
Ann Intern Med. 2009 May 5;150(9):604-12. doi: 10.7326/0003-4819-150-9-200905050-00006.

血管紧张素受体阻滞剂与血管紧张素转换酶抑制剂治疗糖尿病或非糖尿病患者时低血糖发生率较低。

Lower Incidence of Hypoglycemia With Angiotensin Receptor Blocker Versus ACE Inhibitor Therapy in People With or Without Diabetes.

作者信息

Khanimov Israel, Zingerman Boris, Rozen-Zvi Benaya, Shimonov Mordechai, Leibovitz Eyal

机构信息

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Department of Nephrology at the Hasharon Campus, Rabin Medical Center, Petah Tikva, Israel.

出版信息

Clin Diabetes. 2024 Spring;42(2):300-307. doi: 10.2337/cd23-0039. Epub 2024 Jan 12.

DOI:10.2337/cd23-0039
PMID:38694239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11060618/
Abstract

This article describes a study examining the association between treatment with ACE inhibitors or angiotensin receptor blockers (ARBs) and incident hypoglycemia in patients with or without diabetes who were admitted to the internal medicine departments of a tertiary hospital in the Tel Aviv district of Israel. The authors found that treatment with ARBs, but not ACE inhibitors, compared with treatment with neither, was associated with a reduced risk of hypoglycemia regardless of diabetes status.

摘要

本文描述了一项研究，该研究调查了在以色列特拉维夫地区一家三级医院内科住院的糖尿病患者或非糖尿病患者中，使用血管紧张素转换酶抑制剂（ACE抑制剂）或血管紧张素受体阻滞剂（ARB）治疗与低血糖发生之间的关联。作者发现，与未使用任何药物治疗相比，使用ARB治疗（而非ACE抑制剂治疗）与低血糖风险降低相关，且与糖尿病状态无关。